Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL
Authors
Keywords
-
Journal
CIRCULATION
Volume 144, Issue 22, Pages 1750-1759
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-10-28
DOI
10.1161/circulationaha.121.055560
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Road to Approval: a Perspective on the Role of Icosapent Ethyl in Cardiovascular Risk Reduction
- (2020) Xiaowen Wang et al. Current Diabetes Reports
- REDUCE-IT INTERIM: Accumulation of Data Across Prespecified Interim Analyses to Final Results
- (2020) Brian Olshansky et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Reduction in Revascularization With Icosapent Ethyl
- (2020) Benjamin E. Peterson et al. CIRCULATION
- Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT
- (2019) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association
- (2019) Ann C. Skulas-Ray et al. CIRCULATION
- REDUCE-IT USA: Results from the 3,146 Patients Randomized in the United States
- (2019) Deepak L. Bhatt et al. CIRCULATION
- Increased Cardiovascular Risk in Hypertriglyceridemic Patients with Statin-Controlled LDL Cholesterol
- (2018) Gregory A Nichols et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management
- (2018) Om P. Ganda et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks
- (2018) Theingi Aung et al. JAMA Cardiology
- Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real‐World Administrative Claims Analysis of Statin‐Treated Patients With High Residual Cardiovascular Risk
- (2018) Peter P. Toth et al. Journal of the American Heart Association
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Primary Prevention of Atherosclerosis
- (2017) Vijay Nambi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease
- (2016) Robert Klempfner et al.
- Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease
- (2016) Robert Klempfner et al. Circulation-Cardiovascular Quality and Outcomes
- Representation of Patients With Kidney Disease in Trials of Cardiovascular Interventions
- (2016) Ioannis Konstantinidis et al. JAMA Internal Medicine
- Moving Toward Global Primordial Prevention in Cardiovascular Disease
- (2015) Muthiah Vaduganathan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Triglycerides on the rise: should we swap seats on the seesaw?
- (2014) Peter Libby EUROPEAN HEART JOURNAL
- Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease
- (2013) Suetonia C. Palmer et al. ANNALS OF INTERNAL MEDICINE
- Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease
- (2013) Suetonia C. Palmer et al. ANNALS OF INTERNAL MEDICINE
- Inverse relationship between long-chain n-3 fatty acids and risk of sudden cardiac death in patients starting hemodialysis
- (2013) Allon N. Friedman et al. KIDNEY INTERNATIONAL
- Effect of Fish Oil Supplementation on Graft Patency and Cardiovascular Events Among Patients With New Synthetic Arteriovenous Hemodialysis Grafts
- (2012) Charmaine E. Lok JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis
- (2010) Deepak L. Bhatt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
- (2009) Bengt C. Fellström et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started